Chymase inhibitor was able to reduce inflammation in hamster MCD diet- and rat HFC diet-induced NASH models (Tashiro et al., 2010; Masubuchi et al., 2013; Miyaoka et al., 2017). This evidence concerns the gene CMA1 and metabolic dysfunction-associated steatohepatitis.